About

I am an award-winning writer, editor, photographer and designer with more than 30 years of experience in the media. After studying at the University of Leeds, then London and Anglia HEC, I moved to Canada in the 1980s and started out on the radio while also writing for various music and sports publications, and doing freelance photography. I then edited some magazines before working at a science organization, doing communications and editing publications in a programming language called LaTeX that was challenging but exciting.

Following that, I edited a newspaper, spent some time in the US, and then moved back to the UK where I edited a food B2B publication.
I’ve written, and taken photographs for, hundreds of publications around the world, as well as for books, album covers, DVDs, and shot coverage for documentaries. I’ve edited books, written nine of my own, and done redesigns for several publications. And now I’m writing about biotech, as well as creating videos and a weekly podcast.

I’ve done other things, like running an aquarium, teaching photography and drumming (not at the same time), and running football (soccer) refereeing courses.

In what spare time I have, I love spending time with my wife, son and dog, challenging hikes up the Scottish hills (and down again), playing and writing music, watching baseball and soccer, and collecting memorabilia and autographs.

Articles by Jim Cornall

AUM LifeTech secures $400,000 grant for lung cancer immunotherapy program

Scottish biotech startup secures funding for sustainable omega-3 production

Ryvu Therapeutics bags €22M from EIB to work on new cancer treatments

Sanofi drops amcenestrant clinical development program

Programmable medicines company Senda Biosciences closes $123M series C financing

Merck puts up to $37B into Orna Therapeutics circular RNA collaboration

ADVERTISEMENT

Pneumagen embarks on phase 2 proof of concept influenza study

Inhibrx chondrosarcoma treatment gets EC orphan medicinal product designation

Genentech lymphoma treatment gets FDA approval

Remedium raises more funds for osteoarthritis gene therapy candidate

Opthea secures up to $170M in financing for wet AMD treatment

Approval for Small Pharma major depressive disorder clinical trial

ADVERTISEMENT